Clinical evaluation of postoperative chemotherapy based on genetic testing in patients with stage IIIA non-small cell lung cancer.

Journal: Thoracic cancer
Published Date: Apr 30, 2015

Abstract

BACKGROUND: We performed a retrospective analysis to evaluate whether a postoperative chemotherapy selection method based on four tumoral gene expression tests would improve prognosis in patients with stage IIIA non-small cell lung cancer (NSCLC) after surgery.

Authors

  • Jinbai Miao
    Department of Thoracic Surgery Beijing Chao-Yang Hospital Affiliated Capital Medical University Beijing China.
  • Wenqian Zhang
    Department of Thoracic Surgery Beijing Chao-Yang Hospital Affiliated Capital Medical University Beijing China.
  • Xiaoxing Hu
    Department of Thoracic Surgery Beijing Chao-Yang Hospital Affiliated Capital Medical University Beijing China.
  • Shuo Chen
    Department of Thoracic Surgery Beijing Chao-Yang Hospital Affiliated Capital Medical University Beijing China.
  • Bin Hu
    Department of Thoracic Surgery Beijing Chao-Yang Hospital Affiliated Capital Medical University Beijing China.
  • Hui Li
    Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals